PNC Financial Services Group’s Cardiff Oncology CRDF Stock Holding History
Bought
Maintained
Sold
Other funds holding CRDF
PNC Financial Services Group's CRDF Position: Q3 2026 in Review
PNC Financial Services Group sold out of Cardiff Oncology (CRDF) in Q3 2026, closing a stake of 2,218 shares — an estimated $2.88K sold.
PNC Financial Services Group first reported a position in CRDF in Q4 2016 and held it in 16 quarters. The position peaked at $18K in Q4 2021. 63 funds tracked by Wall St. Rank hold CRDF as of Q3 2026.
- PNC Financial Services Group reported no remaining Cardiff Oncology position as of Q3 2026 after selling out during the quarter.
- PNC Financial Services Group sold 2,218 Cardiff Oncology shares in Q3 2026, an estimated $2.88K.
- PNC Financial Services Group first reported a position in Cardiff Oncology in Q4 2016 and held it in 16 quarters.
- PNC Financial Services Group's Cardiff Oncology position peaked at $18K in Q4 2021.
- 63 funds tracked by Wall St. Rank held Cardiff Oncology as of Q3 2026.
Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.